/Companies

StarTric

6 employees on LinkedIn · 3 known investors

Find your way into StarTric

Sign up to find every way you can get introduced to StarTric

  • Your email: who you already know at StarTric, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the StarTric team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.

Founders & leadership

MD
Michele De BonisFounder
OA
Ottavio AlfieriFounder

Investors · 3

Frequently asked questions

What does StarTric do?
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
Who founded StarTric?
StarTric was founded by Michele De Bonis, Ottavio Alfieri.
Who are StarTric's investors?
StarTric's investors include Growth Capital, Growth Engine, NLC.